Antimicrobial drug pricing
Despite the constant development of antimicrobial resistance (AMR), few new antimicrobials are currently becoming available clinically. Alternative approaches, such as different mechanisms to fund their use, are being explored to encourage development of new antimicrobials.
Saved in:
| Main Authors: | Avaneesh Kumar Pandey, Nusrat Shafiq, Ashish Kumar Kakkar, Samir Malhotra, Beth Woods, Christopher Little, Tom Rhodes, Harriet Tuson, Zeshan Riaz, Tom Ashfield, Michael Corley, Ioannis Baltas |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2024-10-01
|
| Series: | Communications Medicine |
| Online Access: | https://doi.org/10.1038/s43856-024-00594-9 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Shortage of essential antimicrobials: a major challenge to global health security
by: Esmita Charani, et al.
Published: (2021-11-01) -
Terminalia arjuna in Chronic Stable Angina: Systematic Review and Meta-Analysis
by: Navjot Kaur, et al.
Published: (2014-01-01) -
Staphylococcus aureus bacteraemia for the general physician: A narrative review of a metastatic infection with malignant complications
by: Ronak J. Shah, et al.
Published: (2024-11-01) -
An Insurance Value Modeling Approach That Captures the Wider Value of a Novel Antimicrobial to Health Systems, Patients, and the Population
by: Mei S. Chan, et al.
Published: (2023-07-01) -
Guttate hypopigmentation in Darier disease: A rare presentation
by: Aradhana Rout, et al.
Published: (2024-01-01)